Enhancing the quality of human life is the core principle behind Sucampo’s research and trial-management success.

• Sucampo’s research is based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.
• Sucampo researches and develops these compounds with particular focus on gastrointestinal, respiratory, vascular and central nervous system diseases.
• Sucampo is currently working with three different product candidates in various development stages from Pre-clinical through Phase III and NDA approval.